If you’re tired of censorship, cancel culture, and the erosion of privacy and civil liberties subscribe to Reclaim The Net.
YouTube channel RutersXiaoFanQi, known for mocking Chinese President Xi Jinping, has been removed. Online free speech advocates claim that the Chinese Communist Party used YouTube’s copyright infringement policies to get the channel banned.
According to Radio Free Asia (RFA) the last video uploaded on the channel mocked Xi for his attempts to become an emperor and claiming honorary university degrees, yet he has an “elementary school level” education. According to a former contributor of the channel, it was removed because of violating copyright policies by using copyrighted music. A current contributor said that Beijing exploited YouTube’s policies of automatically shutting down a channel after receiving too many complaints.
“Those Chinese companies must have been instructed by the government to weaponize copyright claims,” the source said, adding that state-run media might […]
Read the Whole Article From the Source: reclaimthenet.org
What Would You Do If Pharmacies Couldn’t Provide You With Crucial Medications or Antibiotics?
The medication supply chain from China and India is more fragile than ever since Covid. The US is not equipped to handle our pharmaceutical needs. We’ve already seen shortages with antibiotics and other medications in recent months and pharmaceutical challenges are becoming more frequent today.
Our partners at Jase Medical offer a simple solution for Americans to be prepared in case things go south. Their “Jase Case” gives Americans emergency antibiotics they can store away while their “Jase Daily” offers a wide array of prescription drugs to treat the ailments most common to Americans.
They do this through a process that embraces medical freedom. Their secure online form allows board-certified physicians to prescribe the needed drugs. They are then delivered directly to the customer from their pharmacy network. The physicians are available to answer treatment related questions.